Endo - Home | Introducing Keenova and Par Health
On July 31, 2025, Mallinckrodt and Endo joined together to better serve patients and customers with a bold plan for the future. Following the merger, the combined company then spun off its generics and …
Investors | Endo - Press Releases
Aug 1, 2025 · Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader - Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs …
Mallinckrodt and Endo Announce Significant Progress in Proposed …
As announced on March 13, 2025, the proposed Mallinckrodt and Endo transaction envisions the spin-off of the combined generic pharmaceuticals businesses and Endo's sterile injectables business into …
Mallinckrodt, Endo Announce Planned Leadership Team for Merged …
Jun 9, 2025 · Mallinckrodt and Endo commenced mailing of the definitive joint proxy statement/prospectus to shareholders of Mallinckrodt and Endo, respectively, on or about May 12, …
Mallinckrodt and Endo to Combine to Create a Global, Scaled ...
Mar 13, 2025 · About Endo Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver …
Investors | Endo - Overview
Oct 9, 2025 · Endo’s board of directors oversees and advises our leaders to protect the long-term interests of the company and our shareholders. The experienced and independent board members …
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Mar 13, 2025 · Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic priorities XIAFLEX® hit record revenues of $516 million in 2024, up 9% versus …
Endo Completes International Pharmaceuticals Business Divestiture
Jun 17, 2025 · Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International Pharmaceuticals business, …
Endo, Inc. Completes Acquisition of Endo International plc's Assets
MALVERN, Pa., April 23, 2024 / PRNewswire / -- Endo, Inc. ("Endo" or the "Company"), a newly formed entity, today announced that it has successfully completed the previously announced acquisition of …
Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with …
Sep 23, 2025 · Endo now offers ADRENALIN® premixed IV bags in five of the most used concentrations, including the 5 mg and 10 mg which align with ASHP's Standardize 4 Safety Initiative …